On August 30, 2018 Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company that develops antibody-based drug candidates for tumor-directed immunotherapy, reported that the company will participate as a presentation company at the investor conference of the 20th Annual Rodman & Renshaw Global Investment Conference, a joint venture with HC Wainwright & Co., LLC (Press release, Alligator Bioscience, AUG 30, 2018, https://alligatorbioscience.se/alligator-bioscience-presenterar-pa-20th-annual-rodman-renshaw-global-investment-conference/ [SID1234529415]). The conference will take place on 4-6 September on St. Regis New York Hotel in New York, USA.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

CEO Per Norlén will provide a status overview of the company during the company presentation and also participate in individual meetings with investors registered at the conference.

Event: Corporate Presentation at 20th Annual Rodman & Renshaw Global Investment Conference
Date: September 6, 2018
Time: at. 21.25-21.50 CEST (15.25-15.50 local time)
Location: Library (2nd floor); the st. Regis New York Hotel in New York City, USA

The presentation will be live live. To listen to the presentation, please use the following direct link: View Source or visit View Source . The webcast is available for 90 days after the presentation.

For further information please contact:
Cecilia Hofvander, Director Investor Relations & Communications
Telephone: 046-286 44 95
Email: [email protected]

On August 30, 2018 Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a pharmaceutical company focused on the development and commercialization of its proprietary immune modulator, tilsotolimod, for the treatment of cancer, reported that the company will participate in the H.C. Wainwright 20th Annual Global Investment Conference on Wednesday, September 5, 2018 at 2:10 p.m. Eastern Time at the St. Regis Hotel in New York City (Press release, Idera Pharmaceuticals, AUG 30, 2018, View Source [SID1234529172]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Live audio webcast of Idera’s presentations will be accessible in the Investors and Media section of Idera’s website at View Source Archived versions will also be available on the Company’s website after the event for 90 days.

On August 30, 2018 Diplomat Pharmacy, Inc. (NYSE: DPLO), reported that executives will present at three upcoming investor conferences (Press release, Diplomat Speciality Pharmacy, AUG 30, 2018, View Source [SID1234529191]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Baird Global Healthcare Conference in New York: Atul Kavthekar, chief financial officer, will present at 9:40 a.m. ET. Sept. 5.

Wells Fargo Securities Healthcare Conference in Boston: Brian Griffin, chairman and chief executive officer, and Atul Kavthekar, chief financial officer, will present at 8 a.m. ET. Sept. 6.

Morgan Stanley Global Healthcare Conference in New York: Brian Griffin, chairman and CEO; Joel Saban, president; and Atul Kavthekar, chief financial officer, will present at 11:40 a.m. ET. Sept. 12.

Live audio webcasts of each presentation will be available on the investor relations section of Diplomat’s website at ir.diplomat.is. Recordings will be available for approximately 90 days following each presentation at the same URL.

On August 30, 2018 Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, reported its participation at the H.C. Wainwright 20th Annual Global Investment Conference (Press release, Kura Oncology, AUG 30, 2018, http://ir.kuraoncology.com/news-releases/news-release-details/kura-oncology-present-hc-wainwright-global-investment-conference [SID1234529214]). Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is scheduled to present an overview of the company on Thursday, September 6, 2018 at 9:10 a.m. ET / 6:10 a.m. PT. The conference will be held from September 4-6, 2018 in New York.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio webcast of the presentation will be available in the Investors section of Kura’s website at www.kuraoncology.com, with an archived replay available for 30 days following the event.

On August 30, 2018 Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, reported that Chairman and CEO Brent Saunders will participate in a fireside chat at the 2018 Wells Fargo Healthcare Conference in Boston, Massachusetts (Press release, Allergan, AUG 30, 2018, View Source [SID1234529460]). The presentation will begin at 9:05 a.m. Eastern Time on Wednesday, September 5, 2018.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The presentation will be webcast live and can be accessed on Allergan’s Investor Relations website at View Source;. The webcast can also be accessed through the following URL: View Source;

An archived version will be available within approximately two hours of the live presentation and can be accessed at the same location for 180 days.